To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Acridine carboxamide (N-[(2'-dimethylamino)ethyl]acridine-4-carboxamide) is an chemotherapy agent that is being studied in the treatment of cancer. It belongs to the family of drugs called topoisomerase inhibitors.
Additional recommended knowledge
While the agent was well-tolerated in Phase II clinical trials, it did not show efficacy when tested against various types of cancers.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Acridine_carboxamide". A list of authors is available in Wikipedia.|